Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Dec 21, 2022

Concord, Mass. — Comanche Biopharma, a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia, today announced that maternal health, vaccine and drug development expert Allison August, M.D., has been appointed as the company’s Chief Medical Officer. Dr. August, an obstetrician-gynecologist, brings more than 25 years of clinical experience to her position at Comanche Biopharma, including leading multidisciplinary teams to advance early to late-stage clinical programs in the biotechnology industry.